• Toll Free: +1- 844-445-2861
  •   sales@futuregenicreports.com

Packaging

 
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Overactive Bladder Treatment Market 2018 Forecast to 2023

"Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).

Scope of the Report:
This report focuses on the Overactive Bladder Treatment in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Teva (Actavis)

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Anticholinergics
Mirabegron
Botox
Other Drugs

Market Segment by Applications, can be divided into
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder

Published

Read more

SORT BY PRICE







REPORT TYPE

  • USA Office

    244 , Madison Avenue
    New York City, NY - 10016
    United States


    UK Office

    109 ,Straford Street,Leeds
    West Yorkshrie LS11 6JG
    United Kingdom

Copyright © 2018-19 futuregenicreports.com. All rights reserved.